Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.231,48
0,36%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Viridian Therapeutics Inc (VRDN) Viridian Therapeutics Inc (VRDN) Notizie

Viridian Therapeutics Inc

VRDN
16,30
1,72 (11,80%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/5/202414:00BWViridian Therapeutics Announces Inducement Grants Under..
29/4/202414:00BWViridian Therapeutics to Webcast First Quarter 2024..
04/4/202422:01BWViridian Therapeutics Announces Inducement Grants Under..
06/3/202422:01BWViridian Therapeutics Announces Inducement Grants Under..
05/3/202414:00BWViridian Therapeutics to Participate in the Leerink Partners..
28/2/202422:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202422:07EDGAR2Form 8-K - Current report
27/2/202422:01BWViridian Therapeutics Highlights Recent Progress and Reports..
16/2/202414:00BWViridian Therapeutics Appoints Jennifer Tousignant as Chief..
15/2/202402:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:01BWViridian Therapeutics Announces Inducement Grant Under..
25/1/202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202423:12EDGAR2Form SC 13D/A - General statement of acquisition of..
19/1/202423:22EDGAR2Form 8-K - Current report
19/1/202422:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/1/202404:00BWViridian Therapeutics Announces Pricing of Public Offering..
17/1/202422:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202422:01BWViridian Therapeutics Announces Proposed Underwritten Public..
12/1/202422:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202414:08EDGAR2Form 8-K - Current report
08/1/202414:00BWViridian Therapeutics to Present Key 2024 Corporate..
04/1/202414:00BWViridian Therapeutics to Webcast Presentation at the 42nd..
18/12/202317:45EDGAR2Form 144 - Report of proposed sale of securities
18/12/202314:15EDGAR2Form 8-K - Current report
18/12/202313:00BWViridian Therapeutics Announces Positive Clinical Data in..
12/12/202322:19EDGAR2Form 144 - Report of proposed sale of securities
08/12/202322:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/12/202322:22EDGAR2Form 144 - Report of proposed sale of securities
01/12/202322:04EDGAR2Form 144 - Report of proposed sale of securities
30/11/202322:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
21/11/202314:00BWViridian Therapeutics to Participate in 6th Annual Evercore..
13/11/202323:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:01BWViridian Therapeutics Reports Third Quarter 2023 Financial..
08/11/202314:00BWViridian Therapeutics to Participate in the Jefferies London..
03/11/202321:30EDGAR2Form SC 13D/A - General statement of acquisition of..
03/11/202313:00BWViridian Therapeutics Announces Encore Presentations at the..
02/11/202302:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/11/202321:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/10/202313:35EDGAR2Form 8-K - Current report
30/10/202313:30BWViridian Therapeutics Appoints New Chief Executive Officer,..
Apertura: 15,08 Min: 15,01 Max: 15,50
Chiusura: 14,58

La tua Cronologia

NASDAQ
VRDN
Viridian Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network